Clinical trial

BenRalizumab Effect on Airway Remodeling in Severe asTHma

NCT06288516

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2024-03-01

PhasePHASE4

Study timeline

Study start (actual)2024-03-01Date precision: day

Registry last updated2024-03-04

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Asthma; Eosinophilicunresolved

Airway Remodelingunresolved

Interventions

Benralizumab 30 mg/mlDRUG · verified · RxNorm: benralizumab 30 MG/ML

Sponsors & collaborators

Aristotle University Of Thessalonikilead sponsor

Pulmonary Clinic, University of Ioanninacollaborator

Pulmonary Clinic, Democritus University of Thracecollaborator

National and Kapodistrian University of Athenscollaborator

University Hospital of Cretecollaborator

University Hospital of Patrascollaborator

Mapped research locations

ThessalonikiGreece1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06288516 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.